JournalThe Drink00 journal

Zero Pulse

The 1998 Roques report: a historical checkpoint

The 1998 Roques report: a historical checkpoint

To begin

The report by Bernard Roques was delivered to the French Secretary of State for Health in 1998. Its purpose was to compare the dangers of psychoactive substances through several dimensions, including dependence, neurotoxicity, general toxicity and social harm. The report challenged the idea that legal status alone tells us how risky a substance is.

The framework is historical. Present-day mortality, policy and clinical classifications need their own dated evidence. The comparison remains a document of its time, not a universal clinical scorecard.

What the Roques report actually was

The OFDT catalogue record identifies Problèmes posés par la dangerosité des “drogues” as a 1998 report to the Secretary of State for Health, with 195 pages; the work was also published in expanded book form in 1999. It brought together pharmacology, toxicology, dependence, neurobiology and social consequences across legal and illegal substances.

Its method is more useful than a slogan. “Dangerousness” was not one laboratory biomarker: the report compared several dimensions and discussed dose, context and patterns of use. A reproduced historical table in a later public report should therefore be read as a snapshot of that framework, not as a current ranking that can be applied unchanged to every person or product.

A historical framework, not a current dataset

The report offers a late-1990s comparison, not current mortality, legal status, taxation, advertising exposure or public-health outcomes. Each present-day claim needs dated sources and explicit definitions, especially for death counts and attribution.

What the report can and cannot tell us

The report can show how French policy debate in the late 1990s tried to compare substances across dependence, toxicity and social effects. It cannot by itself establish that two substances are “equally dangerous” in every context, predict present-day patterns of use, or settle the legal policy of cannabis in another country.

The public record of the 1998 Senate debate confirms that the report was treated as a proposal for a new comparison of legal and illegal drugs, not as a replacement for legislation or an evergreen medical ranking. Present-day conclusions require new epidemiology, toxicology, policy and regulatory sources.

Reading the comparative dimensions

Labels such as “very strong”, “none” or “very low” need the report’s 1998 definitions and context. Read the comparison as a historical snapshot rather than a timeless league table. Risks vary with dose, frequency, route, combinations, age, health, dependence and social context; no global product ranking based on a handful of biomarkers follows from this framework.

Questions beyond the report

France’s policy lessons from the report are a historical question that requires a defined policy period and evidence. Assessments of alcohol regulation, taxation, advertising, foreign cannabis reforms, legalisation, new psychoactive substances or industry influence cannot be attributed to a 1998 comparison alone. They belong in separate, current investigations with explicit sources.

Non-alcoholic options in the present

Non-alcoholic drinks can give people another option in a social setting. They are not proof that everyone should abstain, and their availability does not by itself reduce harmful drinking. A personal change may involve a month-long break, drinking less often or sustained abstinence; this historical comparison does not choose among those paths.

The useful legacy is methodological: define the harm, define the period, show the evidence, and avoid converting an old comparative framework into a current medical verdict.

Sources

The Roques report belongs to 1998. It remains a valuable historical attempt to compare dependence, toxicity and social harm beyond legal categories, but it is not a current ranking of every psychoactive product and it does not answer today’s policy questions by itself.

Read it as a dated framework. Any present-day claim about mortality, regulation, advertising or legal reform needs new, explicitly dated evidence rather than treating the old table as current.